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GENERAL INTRODUCTION 
Explanation of Dissertation Format 
This dissertation Is presented In the alternate thesis format and 
Includes two manuscripts. The paper In Section I Is concerned with 
the Identification of vitamin D^  metabolites by FT NMR, and has 
been published In Analytical Biochemistry (1). The paper In Section 
II details the identification of a new physiological metabolite of 
vitamin Dg, 24,26-(OH)2D2» and has been published In Biochemistry 
(2). Section III consists of preliminary work studying the effects 
that age has on the vitamin D steroid receptor prepared from Intestine 
and kidney. Included within each of the three sections Is a 
Literature Cited for references noted within that particular body of 
work exclusively. A brief review of the literature is included in the 
General Introduction, and is concerned primarily with firstly, 
differences in the metabolism of vitamin Dg and vitamin D^ , and 
secondly, some characteristics of the 1,25-dihydroxyvltamin steroid 
receptor protein. A Summary and Discussion section is included that 
highlights the major accomplishments of this work, and points out 
areas for further study. Following the Summary and Discussion, there 
is a section of Literature Cited for references to both the General 
Introduction and the Summary and Discussion. 
The doctoral candidate, Nicholas Joseph Koszewski, was the prin­
cipal investigator and author in each of these studies. 
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Differences In the Metabolism of Vitamin and Vitamin 
Vitamin D^ , contrary to Its name, Is not truly a vitamin, but 
rather is now recognized as a pro-steroid hormone (3). The naturally 
occurring form produced by man, vitamin Dg, Is derived from a 
cholesterol-like precursor found In the skin. The direct action of 
sunlight on this precursor, 7-dehydrocholesterol, results In cleavage 
of the B-rlng of the steroid structure that upon thermal Isomerlzatlon 
yields the characteristic seco-sterold (Figure 1). 
Vitamin circulates In the plasma whereupon It undergoes a se­
ries of tissue-specific oxidations that activate the molecule. The 
first of these occurs In the liver to produce 25-OHDg,^  the major 
circulating form of the vitamin. 25-Hydroxyvltamln Dg Is then specif­
ically hydroxylated at the la-posltlon to yield l,25-(0H)2Dg, generally 
considered to be the active hormonal form of the vitamin (3, 4). The 
simplistic picture outlined here Is complicated by the fact that vita­
min Dg can be oxldatlvely metabolized to a variety of products (5). 
Most of these many metabolites have no known biological function, and 
A^bbreviations used: 25-OHD, 25-hydroxyvltamln D; 1,25-(OH)2D, 
1,25-dlhydroxyvltamln D; la-OHD, la-hydroxyvltamln D; 24-OHD, 24-hy-
droxyvltamln D; l,24-(OH)2D, 1,24-dlhydroxyvltamln D; l,24,25-(0H)gD2. 
1,24,25-trlhydroxyvltamln D; l,24,25,26-(OH)^ D, 1,24,25,26-tetrahy-
droxyvltamln D; l,24,25,28-(OH)^ D, 1,24,25,28-tetrahydroxyvltamln D, 
3 
» 
HO 
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HO 
Figure 1. Structures and numbering schemes of the carbon atoms of 
vitamin Ds (upper figure) and vitamin D2 (lower figure) 
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Indeed, many have been Isolated only from either jUi vitro work or ab­
normal physiological conditions. Yet the evidence collected to date 
indicates that vitamin is preferentially metabolized at the side 
chain. In particular, carbon centers C-23, C-24, and C-26 are readily 
susceptible to further oxidation. 
The primary role ascribed to vitamin Dg is the maintenance of 
calcium homeostasis (3, 4), although its Importance In cell differen­
tiation and Immune function has recently been recognized (6-8). The 
interaction of the activated hormone with target tissues, primarily 
the intestine, kidney, and bone, results in a net Increase in the 
extracellular calcium concentration. A lack of the vitamin leads to a 
loss of calcium from the body. The importance of the vitamin is, in 
retrospect, readily evident as the incidence of ricketé, a debilitat­
ing disease afflicting mainly children and characterized by poor bone 
formation, escalated to epidemic proportions during the 19th and early 
20th centuries in emerging industrialized nations. During this time 
vast segments of the population migrated to large Industrial cities 
where often they worked long hours inside factories, and lived in 
cramped quarters that afforded little sunshine. 
It was during the early 20th century that two distinct anti­
rachitic factors were isolated and Identified (3). The first factor 
to be fully characterized was designated vitamin Dg (Figure 1), while 
the structure of vitamin Dg became evident some 5 years later. Vita­
min Dg readily undergoes the same hydroxylatlons in the liver and kid­
ney described for vitamin Dg leading to the comparable activated 
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molecule, 1,25-(OH)(9). Vitamin Dg evokes the same biological re­
sponse in man as vitamin Dg, and can be readily obtained by the irra­
diation of ergosterol, an abundant yeast sterol. 
Vitamin and related metabolites have been shown to contribute 
significantly to the overall vitamin D status in humans consuming sup­
plemental vitamin Dg (10-13). It has also been determined that vi­
tamin Dg can readily pass into the milk of lactatlng mothers and there­
by be ingested by the suckling infant (12, 14). In addition, a vita­
min Dg supplement was observed to significantly raise the 25-OHD plasma 
concentrations in subjects not previously using a supplement (15, 16). 
Horst and Llttledlke measured the concentration of vitamin and vi­
tamin Dg metabolites in the plasma of various species of both young 
and aged domestic animals, and found a significant amount of 25-OHD2 
present in all cases (17). Although the assay used to measure plasma 
1,25-(OH)gD could not differentiate between the two vitamin forms, 
there was a significant decline in circulating 1,25-(OH)gD with age. 
Vitamin can be metabolized in a similar fashion to produce 
several metabolites analogous to the vitamin system. Including the 
hormonal form of the vitamin. Simple inspection of the side chain, 
however, would imply that differences between the metabolism of vita­
min Dg and vitamin might exist. The presence of unsaturation at 
carbon centers C-22/C-23, along with the additional methyl group at 
C-24, would seem to preclude the existence of the same metabolic path­
ways for the two vitamins. Indeed, early reports indicated that 
chickens and New World monkeys were not responsive to the use of 
6 
vitamin Dg as an anti-rachltlc factor (18-20). Chickens evidently 
possess the necessary enzymes to convert the vitamin into its active 
form (21). Hoy et al. have shown that the discrimination against vi­
tamin Dg in chickens occurs because of a faster clearance of 25-OHD2 
and 1,25-(0H)2D2 from the plasma in comparison to their vitamin 
analogs (22). The plasma clearance of the parent vitamins was roughly 
equivalent. 
Horst et al. investigated differences in the metabolism of the 
two vitamins when administered orally to the pig, rat, and dairy calf 
(23, 24). This work clearly established that, when presented simulta­
neously with equal dietary quantities of the two vitamins, pigs and 
calves discriminated against vitamin Dg and its metabolites. Rats, on 
the other hand, circulated higher concentrations of vitamin D^ , but 
25-OHD2 dominated as the major component of the 25-OHD in plasma. 
Vitamin has been shown to be less hypercalcemic and less toxic 
than is vitamin Dg (25, 26). Vitamin was determined to be as effec­
tive in the treatment of childhood renal osteodystrophy, and presented 
fewer hypercalcemic side-effects than did vitamin (27). In addi­
tion, la-hydroxyvltamln D has proved to be an important therapeutic 
agent because of its effectiveness in stimulating calcium absorption 
in the gut and mobilizing calcium from bone (28). The vitamin ana­
log was as effective as the vitamin Dg derivative in standard blo-
assays. This same study, however, Indicated that la-OHD^  was 5-15 
times less toxic when given to rats than was la-OHD^ . 
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Differences have also been evident In the metabolism of vitamin 
Dg and vitamin In subcellular fractions from both rat and human 
liver (29, 30). Vitamin was at least two times more effectively 
converted to Its 25-hydroxylated analog In mitochondrial or microsomal 
preparations. The authors further suggested that the Impaired 25— 
hydroxylatlon of vitamin Dg, thus preventing Its subsequent activa­
tion, may account for the sterols lower toxicity. 
The 24-positlon of vitamin Dg, In contrast to the similar position 
In vitamin D^ , can be considered to be a highly reactive site. It is 
both a tertiary carbon as well as an allyllc position, and the forma­
tion of a reactive intermediate (radical, cation) there would be highly 
stabilized. The proximity of this reactive center to the 25-positlon 
would afford the possibility of hydroxylatlon at C-24 in vitamin D^ . 
This is Indeed the case, as Jones et al. demonstrated, when 24-OHD2 
was Isolated from the plasma of male rats treated with 100 lU of radio-
labelled vitamin Dg (31). Engstrom and Koszewskl have determined that 
production of both isomers of 24-OHD2 occurs in liver homogenates from 
a variety of species, and actually exceeds the formation of either 
25-OHD metabolite (32). 
It has recently been shown that 24-OHD2 can undergo la-hydroxyla­
tlon to form 1,24-(0H)2D2, a compound rivalling 1,25-(OH)2D in bio-
potency, though the oxidation occurs less efficiently than for either 
25-OHD (33). This same study Indicated that the concentration of 
24-OHD2 in plasma matched that of 25-OHD2 in rats given pharmacologi­
cal doses of vitamin D2. 24-Hydroxyvltamin D2, however, was shown to 
8 
have a much lower affinity for the vitamin D receptor. The limited 
ability of ZA-OHDg to bind to the receptor, a step necessary for the 
initiation of a biological response, may aid in explaining the reduced 
toxicity of vitamin D^ . 
Horst et al. was able to isolate 1,24,25-(OH)from either bo­
vine or chick kidney homogenates (34). The formation of this metabo­
lite represented an unequivocal deactivation of the vitamin mole­
cule. Conversely, the comparable vitamin Dg analog, l,24,25-(0H)gDg, 
maintains significant biological activity, and must undergo further 
side-chain oxidation to be rendered Inactive. Reddy and Tserng iso­
lated and characterized 1,24,25,26-(0H)^ D2 and 1,24,25,28-(OH)from 
rat kidney perfusions (35). Using 1,25-(0H)2D2 as the substrate, they 
were able to show that production of these new metabolites proceeded 
through the initial formation of 1,24,25-(OH)^ Dg. The authors sug­
gested that these pathways, which lead to unique vitamin D^ -speciflc 
metabolic products, may in part account for the decreased toxicity 
observed with vitamin D^ . 
Steroid Receptor Protein for 1,25-Dihydroxyvitamln 
The vitamin D receptor has been shown to be a large, acidic pro­
tein that binds 1,25-(OH)with high affinity. The binding of the 
hormone is thought to result in conformational changes within the pro­
tein, leading to an Increased affinity for nuclear components. The 
receptor-hormone complex is then believed to be able to recognize and 
bind to specific sequences of DNÂ (termed response elements; 36, 37), 
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and alter transcriptional events within the cell. The characteristics 
of the vitamin D steroid receptor have been reviewed in great detail 
elsewhere (38-41). What follows Is Intended to be only a cursory dis­
cussion of some of the more salient features of the 1,25-(OH) 
steroid receptor protein. 
The intestine, a primary target organ for 1,25-(OH)gDg, has been 
the site that has received the most intense study because of its rela­
tively high concentration of vitamin D receptor. Nevertheless, the 
receptor constitutes approximately a mere 0.001% of the soluble pro­
tein present in the intestinal mucosa (39). Early reports found that 
the receptor preferentially bound 1,25-(OH)20^  with high affinity 
(Kj"3.2 X 10 ^ M^), and the complex sedlmented at 3.7S in high salt 
sucrose density gradients (42, 43). These values are in generally 
good agreement with subsequent work on the receptor. 
Studies on the steroid receptor have been greatly facilitated by 
the ability to generate monoclonal antibodies against the protein. 
Pike et al. were able to prepare a sufficient quantity of purified 
receptor (ca. 20% pure) from 10 kilograms of chicken intestinal mucosa 
to successfully develop hybridomas that secreted antibodies directed 
against the chicken receptor (44-46). One of these monoclonal anti­
bodies, designated 9â7yi has exhibited good cross-reactivity with vi­
tamin D receptors from other species (47), and is used in the disser­
tation work presented here. More recently, monoclonal antibodies have 
been generated against the porcine intestinal receptor as well (48). 
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The size of vitamin D receptors from various species has been 
determined using denaturing gel electrophoresis and subsequent immuno­
logic detection of the protein. Mammalian receptors typically range 
In size from 48-55 kilodaltons (49-51). The chicken vitamin D recep­
tor appears as two bands with molecular weights of 60 and 58 kilodal­
tons (49, 52, 53). It was suggested that the lower molecular weight 
protein may arise from cleavage of the larger molecule, although syn­
thesis from multiple receptor transcripts or translation start sites 
has not been ruled out. 
Proteolytic mapping of the chicken intestinal receptor revealed 
the presence of two distinct functional domains of the protein. Cleav­
age with trypsin under controlled conditions generated a 20 kllodalton 
DNA-blndlng fragment that could b'e detected immunologically, and a 
40-45 kllodalton fragment that retained the hormone (54). Endogenous 
proteolysis, however, produced a 45-46 kllodalton fragment that was 
now visible in Immunoblots, specifically bound the hormone, but still 
failed to bind to DNA-cellulose (48). The smaller fragment (ca. 15 
kilodaltons) generated from this latter case could not be detected. 
Endogenous proteolysis evidently cleaves in or near the DNA-blndlng 
domain of the receptor so as to render it biologically inactive. Ex­
posure of the chicken receptor to carboxypeptldase A resulted in the 
immunologic detection of a 56 kllodalton fragment that retained DNA-
blndlng, but was no longer capable of binding hormone (55). The loss 
of approximately 40 amino acids from the carboxyl terminus produces a 
protein Incapable of binding hormone. 
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Monoclonal antibodies permitted the screening of cDNA clones en­
coding the vitamin D receptor from various expression libraries. 
Clones have been identified that encode the avian (56) and several 
mammalian Intestinal receptors (57, 58). Expression of the clone for 
the human intestinal receptor has resulted in a functional protein 
indistinguishable from the native receptor (57). The ability to ex­
press intact receptor, or selected domains, from these systems should 
greatly facitlitate a more detailed understanding of the physical pro­
perties of the protein. 
The complete or partial deduced amino acid sequence for several 
vitamin D receptors has now been realized, and the degree of homology 
between several species examined (56-59). The analyses indicated that 
the vitamin D receptor is highly conserved between species, with the 
avian protein being the largest at approximately 60 kilodaltons. 
There is a general decrease in receptor size as one proceeds up the 
evolutionary ladder with the human receptor being the smallest (ca. 48 
K) examined thus far. 
A comparison of the sequence of the human vitamin D receptor with 
other similar hormone receptor systems indicated that several conserved 
regions existed (60). One of these, a cysteine-rich region near the 
amino terminus, has been linked to the formation of finger-like struc­
tures coordinately bound to zinc. These finger-like projections are 
believed to be responsible for the binding of the molecule to DNA. 
Divalent cations, particularly zinc and cadmium, have been shown to 
stabilize the DNA-binding ability of the vitamin D receptor (38). A 
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second conserved region has been identified among the various receptors 
that lies within the hormone-binding domain, but whose exact role has 
yet to be defined. The highest degree of homology, however, existed 
between the vitamin D and thyroid receptors. There is a unique region 
near the carboxyl terminus that is highly homologous between these two 
proteins exclusively. This finding may indicate that these receptors 
evolved from a single primordial gene. 
The vitamin D receptor is capable of being covalently modified 
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via phosphorylation. Treatment of 3T6 fibroblasts with [ P]-ortho-
phosphate in the presence and absence of hormone clearly established 
that the receptor was incorporating the label when exposed to 1,25-
(OH)gDg (61). Receptor Isolated from hormone-treated 3T6 cells also 
displayed a perceptible decrease In its electrophoretic mobility rela­
tive to an untreated control, an observation consistent with protein 
phosphorylation (49, 61). 
Hormone treatment has also resulted in significant up-regulatlon 
of receptor concentration, both iji vivo (62) and Iji vitro (49, 63-65). 
In vitro translation of receptor m-RNA Isolated from 3T6 cells grown 
In either the presence or absence of hormone indicated that far more 
translatable message existed in the treated cells (49). Furthermore, 
the ^  vitro translated receptor displayed the same electrophoretic 
mobility as receptor Isolated directly from untreated cells. This was 
a further indication that in treated cells the receptor undergoes post-
translatlonal modification, i.e. phosphorylation (49, 61). 
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The vitamin D receptor has been detected in a wide variety of 
tissues (39, 40). Immunocytochemlcal analyses demonstrated that the 
protein is often localized to certain cell types within a tissue (47, 
66, 67). For example, immunoreactivity was observed in epithelial 
cells of villi and crypts in the duodenum and in tubular cells of the 
kidney. Many other tissues where the receptor has been identified are 
not directly related to the maintenance of calcium homeostasis, and 
the exact role of the receptor within them remains to be elucidated 
(6-8) .  
Several approaches have been taken to ascertain the exact cellu­
lar location of the unoccupied receptor. Immunocytochemlcal staining 
for the protein has placed it exclusively within the nuclear compart­
ment (66, 6i^ ). This result was consistent with earlier observations 
that indicated the receptor was predominantly localized to the 
nuclel/chromatln in low-salt extractions of homogenized tissue (68). 
Alternatively, the cytoplasmic/nuclear ratio of unoccupied receptor 
was determined to be better than 2:1 when extracted at physiological 
salt concentrations (69). Walters et al. used cell enucleation with 
cytochalasln B to demonstrate a similar distribution In two kidney 
cell lines (70). These contradictory results, sometimes emanating 
from the same laboratory, indicate the recent turmoil this subject has 
created (41, 71), but current dogma favors a mostly nuclear localiza­
tion for the unoccupied vitamin D receptor. 
The interaction of 1,25-(OH)gDg with its receptor protein has 
been shown to mediate the biological response of the hormone In a 
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number of systems. Induction of a 25-OHD^ -24-hydroxylase enzyme 
activity has been demonstrated In a dose-dependent fashion for 
l,25-(0H)2Dg In several cell culture systems (72, 73). 1,25-Dlhydroxy-
vltamln Dg was effective In suppressing colony formation by a number 
of cultured cancer lines, but only In those cell lines where It could 
be demonstrated that a receptor for the hormone existed (74). In these 
studies the biological response generated by other vitamin D metabo­
lites was dependent upon that particular molecule's affinity for the 
receptor. Good correlation was also found between nuclear uptake of 
1,25-(0H)2, receptor occupancy, and Increased transcription and syn­
thesis of the vitamin D-dependent calcium binding protein In chicken 
intestine (75). 
Vitamin D-dependent rickets type II Is a hereditary disease state 
that provides additional evidence to support the receptor-mediated 
mode of action for 1,25-(OH)(76, 77). The disease Is character­
ized by hypocalcemia, secondary hyperparathyroidism, normal serum 
25-OHD, and mildly to markedly elevated serum 1,25-(OH)20^  concentra­
tions. Type II rickets Is attributed to a dysfunction of the vitamin 
D receptor that can manifest Itself In many ways. Receptors isolated 
from cultured skin fibroblasts from one group of patients displaying 
type II rickets demonstrated a defect In binding to DNA-cellulose (78, 
79). Still another case that was recently described Indicated that 
the protein exhibited an abnormally low affinity for the hormone (80). 
A kidney cell line has been Identified that possesses a variant recep­
tor also displaying a low affinity for hormone and may prove useful as 
15 
a model system to study this particular abnormality (81). Finally, 
the disease may present Itself In a form that Is characterized by nor­
mal affinity of the receptor for hormone, and normal or near normal 
elutlon of the receptor-hormone complex from DNA-cellulose (79). In 
these cases the receptor-hormone complexes failed to localize In the 
nucleus. Indicating either an additional domain on the receptor not 
measured In these assays as defective, or the assays used to measure 
hormone binding and DNA binding may not accurately reflect cellular 
conditions. 
16 
SECTION I. 
USE OF FOURIER TRANSFORM NMR IN THE IDENTIFICATION OF 
VITAMIN Da METABOLITES 
17 
INTRODUCTION 
The Identification of vitamin D metabolites has been achieved 
primarily through the use of uv absorbance and mass spectroscopy (1). 
The sensitivity of mass spectroscopy (25-200 ng) has been well suited 
to the study of vitamin D metabolism, particularly because most 
metabolites are present in biological fluids in microgram to nanogram 
quantities. The interpretation of mass spectral data, however, often 
is not straightforward. Specific chemical modifications of the 
metabolite are often required, followed by additional mass spectral 
analysis. Routine use of a rapid, sensitive, and nondestructive 
analytical technique for assigning the structures of vitamin D metabo­
lites is needed. 
A method that best meets these criteria is FT NMR spec­
troscopy.^  The widespread use of NMR to aid in the 
A^bbreviations used: FT, Fourier transform; D, deuterium; 
24-OHD2, 24-hydroxyvitamin D2; 25-OHD2, 25-hydroxyvltamln 0%; 24,25-
(OlDaDg, 24,25-dihydroxyvitamin 0%; 24,26-(0H)2D2, 24,26-di- hydroxy-
vltamln Dg; 1,24,25-(OH)$02, 1,24,25-trihydroxyvltamin D2; 1,25,26-
(0H)3Dg, 1,25,26-trihydroxyvitamin Dgi 1,25,28-(OH)302, 1,25,28-trihy-
droxyvltamln D2; A22-1,25-(0H)2D3; A22-l,25-dihy- droxyvitamln D3; 
1,25-(0H)2D3, 1,25-dlhydroxyvitamin D3. 
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identification of new vitamin D metabolites has been limited by the 
relatively large amounts of material and extended data acquisition 
times needed to obtain a suitable spectrum (1, 2). In spite of these 
limitations, significant insights concerning the solution conforma­
tions of vitamin Dg and its analogs have been described (3-9). It is 
the advent of FT NMR, coupled with superconducting magnets and their 
routine use in the laboratory, that will undoubtedly lead to an 
increased emphasis on NMR spectroscopy as a means of identifying 
vitamin D metabolites on a microgram scale. At the same time, inter­
est in the metabolism and biological properties exhibited by vitamin 
Dg (Fig. 1) is leading to Increased research efforts in this area 
(10-13). In conjunction with these efforts, we now report our NMR 
findings for a variety of vitamin Dg analogs. 
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Figure 1. Structure and numbering scheme of the carbon atoms of 
vitamin D2 
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MATERIALS AND METHODS 
Chemicals and Glassware 
Deuterated chloroform was purchased from Aldrlch Chemical Co., 
Milwaukee, WI (99.8 at.Z D) and MSD Isotopes, Montreal, Canada (99.96 
at.% D). Deuterium oxide was purchased from Aldrlch Chemical Co. 
(99.8 at.% D). Acetone-dg was purchased from MSD Isotopes (99.5 at.% 
D). Glass Inserts for the 5-mm NMR tubes were purchased from Wllmad 
Glass Company, Inc. (Buena, NJ). Crystalline vitamin D2 was purchased 
from Sigma Chemical Co. (St. Louis, MO). The compounds 1,25,26-
(0H)sD2, 1.25,28-(0H)sD2, A22-1,25-(0H)2Ds, and l,25-(0H)2Ds were 
prepared by E. G. Bagglollnl and M. R. Uskokovlc (unpublished results). 
Synthetic 24(R),25-(0H)2D2 was a gift from Dr. Kobayashl, Department 
of Hygenlc Sciences, Kobe Women's College of Pharmacy, Kobe Japan. 
1,24,25-Trlhydroxyvltamln D2 was prepared as described by Horst et al. 
(14). The remaining vitamin D2 metabolites were isolated from bovine 
plasma and purified by HPLC. The identities of these metabolites were 
confirmed by their comigratlon on HPLC with known standards, by 
electron-impact mass spectrometry (data not shown), as well as by 
their 300-MHZ ^  NMR spectra (Tables 1 and 2). 
H^ NMR Analysis 
 ^NMR spectra were recorded on a Nlcolet 300-MHZ FT spectrometer 
equipped with a NMC-1280 computer. A 55° flip-angle was used and 
Table 1. 300-MHz FT ^  NMR data of vitamin Dg metabolites 
Proton Chemical shifts (6, ppm), signal multiplicités,* and coupling constants (J, Hz) 
assignment ZA-OHDg 25-OHD2 24,25-(0H)2D2 24,26-(0H)2D2 
6 6.22 d 11.4 6.22 d 11.4 6.22 d 11.4 6.22 d 11.1 6.22 d 11.1 
7 6.02 d 11.4 6.02 d 11.7 6.02 d 11.1 6.02 d 11.1 6.02 d 11.4 
22. 23 5.18 m 5.43 m 5.32 m 5.56 m 5.48 m 
19Z 5.04 brs 5.04 brs 5.03 brs 5.03 brs 5.03 brs 
19E 4.81 brs 4.80 brs 4.81 brs 4.80 brs 4.81 brs 
3a 3.94 m 3.95 m 3.94 m 3.93 m 3.94 m 
28 0.90 d 6.6 1.20 s 0.99 d 6.9 1.27 s 1.30 s 
21 1.01 d- 6.6 1.03 d 6.6 1.03 d 6.6 1.04 d 6.6 1.05 d 6.6 
26. 27 0.83 d 6.6 0.88 d 6.3 1.16 s 1.21 s 3.66 m 
0.81 d 6.6 0.87 d 6.6 1.12 s 1.18 s 0.81 d 6.9 
18 0.54 8 0.56 s 0.55 s 0.56 s 0.56 s 
A^bbreviations used: brs, broad singlet; d, doublet; m, multiplet; s, singlet. 
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Table 2. 300-MHz FT H NMR data of la-hydroxylated vitamin Dg and vitamin D, metabolites 
Proton Chemical shifts (6, ppm), signal multiplicities,* and coupling constants (J, Hz) 
assignment 1.24,25-(0H)9D2 1,25,26-(0H)3D2 1,25,28-(0H)9D2 A22,1,25-(0H)2D3 1,25-(0H)2D3 
6 6.37 d 11.1 6.37 d 11.1 6.36 d 10.8 6.37 d 11.4 6.37 d 11.4 
7 6.00 d 12.0 6.00 d 11.4 6.02 d 10.8 6.00 d 11.4 6.00 d 10.8 
22, 23 5.56 m 5.37 m 5.43 dd 15.3,9.0 5.38 m 
5.21 dd 15.5,9.3 
19Z 4.99 brs 4.99 brs 4.97 brs 4.99 brs 5.00 brs 
19E ' 5.31 brs 5.31 brs 5.34 brs 5.31 brs 5.32 brs 
le 4.42 m 4.43 m 4.45 m 4.42 m 4.42 m 
3a 4.23 m 4.23 m 4.24 m 4.23 m 4.22 m 
28 1.27 s 0.98 d 6.9 3.83 m 
3.70 m 
21 1.04 d 6.6 1.04 d 6.9 1.04 d 6.3 1.03 d 6.6 0.93 d 6.0 
26, 27 1.21 s 3.48 m 1.22 s 1.19 s 1.21 a 
1.19 s 1.06 s 
18 0.56 s 0.55 s 0.56 s 0.56 s 0.53 s 
A^bbreviations used: brs, broad singlet; d, doublet; m, multiplet; s, singlet. 
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samples received a ô-ys pulse. The sweep width was 4000 Hz. The data 
acquisition time was 2.05 s, and a delay time of 1.00 s was used. The 
elapsed time necessary to obtain a suitable spectrum varied from a few 
minutes to 4 h, depending upon the concentration of metabolite. 
Spectra were obtained In standard 5-mm NMR tubes at metabolite concen­
trations of from 0.09 to 20 mM (5 yg-1 mg/130 yl). Chemical shifts 
were measured relative to chloroform at 7.24 ppm. Coupling constants 
were generated by the NMC-1280 computer. 
To maintain compound purity and to reduce water Interference In 
data collection, the NMR tubes were prepared In the following manner. 
The tubes were Initially rinsed with a 1 M ammonium hydroxide solution 
followed by distilled water and reagent-grade ethanol. After the 
tubes were dried under argon, deuterium oxide was added, and the tubes 
were allowed to stand for 24-48 h at room temperature. When the glass 
Inserts were used, deuterium oxide was added both to the 5-mm tube and 
to the cavity of the Insert, and the pieces were assembled together. 
After 24-48 h In DgO, the tubes were rinsed with acetone-d^  and dried 
under argon. Vitamin D compounds, stored In ethanol solution, were 
dried under argon, dissolved in a minimum amount of chloroform-^ , and 
dried again before being transferred via chloroform-^  into the NMR 
tube. Chloroformed also was added to the cavity of the glass insert. 
The samples were then shielded from light and stored over dry ice 
prior to their use. 
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RESULTS AND DISCUSSION 
We sought to exploit the recent advances made In FT NMR spectros­
copy as an aid to determine the structures of vitamin Dg metabolites 
on a microgram scale. The metabolism of vitamin D2 Is particularly 
well suited to study by NMR because the chlrality and unsaturation 
that already exist in the side chain create unique resonances for 
those methyl groups and oleflnlc protons. Alterations in the struc­
ture of the side chain should be readily observable by a change in 
chemical shift and/or signal multiplicity of the characteristic 
resonance. Examination of the values listed in Table 1 reveals that 
this is indeed the case. The side-chain hydroxylatlon of vitamin Dg 
at C-25 results in distinct singlets for the C-26 and C-27 methyl 
group resonances in addition to their shift downfleld to 61.16 and 
61.12. At the same time the doublet corresponding to the C-28 methyl 
group and the multiplet of the side-chain oleflnlc protons also are 
shifted slightly downfleld. 
Crucial to our recent identification of a new vitamin Dg metabo­
lite, 24,25-(0H)2D2 (N. J. Koszewski, J. L. Napoll, T. A. Reinhardt, 
and R. L. Horst, submitted for publication), was the interpretation of 
the 300-MHz NMR spectrum. We rationalized that the doublet appear­
ing at 61.05 (J " 6.6 Hz) corresponded to the C-21 methyl group. This 
was despite the fact that the literature NMR values for vitamin Dg 
have placed the position of this group In the vicinity of 60.90 and 
the C-28 methyl group near 61.01 (9, 15). Yet, the overwhelming body 
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of evidence accumulated In our study indicated that the metabolite had 
been hydroxylated at the C-24 position, giving rise to a singlet for 
the C-28 methyl group at 61.30. To reconcile this difference, we 
examined the NMR spectra of a number of vitamin Dg metabolites. 
Among the most interesting findings from this work were the 
assignments of the C-21 and C-28 methyl groups. Both of these signals 
appear as doublets in vitamin Dg (J - 6.6 Hz). The previous assign­
ment of the C-21 methyl group to the signal at 60.90 was most likely 
made on the basis of a direct comparison with the signals arising from 
vitamin Dg. In vitamin Dg, the C-21 methyl group signal appears as a 
doublet at 60.92. It would therefore follow that the corresponding 
peaks in vitamin Dg should arise from the same source. An examination 
of the data presented in Tables 1 and 2 leads to a different conclu­
sion. That is, the C-21 methyl group gives rise to the doublet at 
approximately 61.01, whereas the doublet in the region of 60.90 
actually corresponds to the C-28 methyl group. In the metabolite 
series consisting of 24-0HD2, 24,25-(0H)2D2, 24,25-(0H)2D2» and 
l,24,25-(0H)3Da, a doublet consistently appears near 61.03 (J » ca. 
6.6 Hz). This signal can only be ascribed to the C-21 methyl group 
because replacement of the C-24 proton by a hydroxyl group precludes 
splitting of the C-28 methyl group into a doublet. In all of the C-24 
hydroxylated compounds examined in this series, the C-28 methyl group 
appears as a singlet shifted farther downfleld in conjunction with the 
C-24 hydroxylatlon. The situation for 25-0HD2 is similar in that the 
C-21 methyl group again appears as a doublet at 61.03. However, the 
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C-28 methyl resonance now appears as a doublet at 60.99, shifted 
downfleld as a result of Its proximity to the C-25 hydroxyl group. 
.As further confirmation of these findings, we examined (Table 2) 
the 300-MHz NMR spectra of A22-l,25-(OH)aDs (Fig. 2) and 1,25,28-
(OHOgDa. The side chain for this synthetic vitamin Dg metabolite 
resembles that of 25-OHD2 in every respect except for the replacement 
of the C-28 methyl group with a proton. Now the C-21 methyl group 
appears as a doublet at 61.03, in excellent agreement with our obser­
vations for the various vitamin Dg metabolites. The position of the 
C-21 methyl signal in 1,25-(OH)20$ is located at 60.93. In the NMR 
spectrum of synthetic l,25,28-(OH)sD2, the C-28 methylene resonances 
are shifted downfleld in accordance with the presence of the C-28 
hydroxyl group. The C-21 methyl group again appears as a doublet at 
61.04. Clearly then, the C-21 methyl group is significantly de-
shielded in the presence of C-22/C-23 unsaturation relative to its 
position in vitamin Ds. On the other hand, the upfield position of 
the C-28 methyl group with respect to the C-21 methyl group in vitamin 
Dg might be attributable to some shielding effect exerted by the C-26 
and C-27 methyl groups. 
Although the aforementioned uniqueness of the vitamin D2 side 
chain lends Itself to the monitoring of its metabolism by ^ H NMR, 
previous limits on the amount of metabolite required to obtain a 
suitable spectrum have been prohibitive (1). To be of any practical 
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Figure 2. 300-MHz H NMR of 1 mg of A22-1,25-(0H)2D3. The position 
of the C-21 methyl signal appears at 61.03, shifted 0.1 ppm 
downfleld from its position in l,25r(0H)gD3, and is in 
good agreement with our vitamin Dg H data 
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use In the study of vitamin Dg metabolism, the amount of material 
required to obtain a spectrum needed to be reduced. Using a 300-MHz 
NMR spectrometer and computer, we have successfully worked toward 
meeting this requirement. To date, our best results have been achieved 
using a 55* flip-angle and a 6-ys pulse with a sweep width of 4000 Hz. 
The availability of Isotoplcally enriched chloroform-d solvent (99.96 
at.% D) and pretreatment of the NMR tubes with D^ O together greatly 
reduced the size of extraneous peaks and resulted In better baseline 
resolution. The use of a glass insert also allowed us to Increase the 
concentration of the sample by reducing the volume to 130 pi of 
chloroform-d/metabollte In a standard 5-mm FT NMR tube. This effec­
tively places more of the sample within the receiving colls of the NMR 
Instrument. Presented In Fig. 3 Is a 300-MHz ^ H NMR spectrum of 5 ug 
of 24(R),25-(0H)2D2 Isolated from bovine plasma. Taken in slightly 
less than 4 h (ca. 4800 scans), this spectrum permits detailed exami­
nation of the regions of particular interest, namely, from 7.00 to 
3.50 ppm and from 1.35 to 0.25 ppm. These areas account for the 
oleflnlc, hydroxyllc, and methyl group protons and, as such, provide a 
wealth of information concerning the structure of a metabolite. In 
addition, the nondestructive nature of NMR work permits the ready 
recovery of the compound in question. 
Regarding 24,25-(0H)2D2, there are several discrepancies in the 
literature concerning the ^  NMR assignments made for the C-26, C-27, 
and C-28 methyl groups of this compound (16, 17). We unequivocally 
established the Identity of our biologically prepared 24(R),25-(0H)2D2 
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Figure 3. 300-MHz NMR of 5 pg of 24(R),25-(0H)2D2. Data collec­
tion required slightly less than 4 h. This spectrum per­
mits detailed examination of areas of particular Interest, 
namely, the oleflnlc, hydroxyllc, and side-chain methyl 
group resonances 
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on two different HPLC solvent systems. In our study, the C-26 and 
C-27 methyl groups appear as distinct singlets at 51.18 and 61.21. 
This chemical shift In equivalence can be attributed to their prox­
imity to the C-24 chlral center. In vitamin Dg Itself, the observed 
resonance of the C-28 methyl protons Is 0.07 and 0.09 ppm farther 
downfleld than the C-26 and C-27 methyl group protons (Table 1). 
Hydroxylation of both C-24 and C-25 would be expected to produce 
downfleld shifts of nearly the same magnitude for these three methyl 
groups from their relative positions in vitamin D,. This is in 
agreement with our assignment of the C-28 methyl protons to the signal 
at 51.27, 0.06 and 0.09 ppm downfleld from the assigned C-26 and C-27 
methyl resonances. In fact, using our data for vitamin D2, 24-OHD2, 
and 25-OHD2, one can accurately predict the additive effects seen for 
dlhydroxylatlon in the chemical shifts of these methyl groups for 
24,25-(0H)2D2 and 1,24,25-(0H)3D2 (Tables 1 and 2). 
Also of some Interest in characterizing vitamin Dg metabolites is 
the relative position of the complex multiplet corresponding to the 
C-22/C-23 oleflnic protons. This position is dependent upon the 
number and sites of hydroxylation in the side chain. A downfleld 
shift of 0.25 ppm is evident for hydroxylation at C-24 alone, whereas 
the same type of shift occurs to a lesser extent (0.14 ppm) for C-25 
hydroxylation alone. The effect of dlhydroxylatlon can be seen to be 
nearly additive in the 0.38-ppm downfleld shift observed for this 
multiplet in the spectra of 24,25-(0H)2D2 and 1,24,25-(0H)3D2. 
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There seems to be a general misconception concerning the assign­
ments of the 19Z and 19E protons In la-hydroxylated vitamin D metabo­
lites. When a vitamin D metabolite becomes hydroxylated at the 
la-posltlon, the normal assignment of 19Z and 19E protons becomes 
reversed. This can be attributed to a change In the assigned priority 
of the C-10 substituent groups In conjunction with the oxygen atom now 
present at the 1-posltlon. As such, what was 19Z In the unsubstltuted 
case now becomes 19E In the la-hydroxylated compound. We have re­
flected this view In our assignments made In Tables 1 and 2. 
We have successfully obtained high-resolution NMR spectra of 
as little as 5 yg of a vitamin D2 metabolite. This Increase In 
sensitivity can be attributed to superconducting magnets for FT NMR 
Instruments,.advances In computer software, and careful sample prepa­
ration. Although high-resolution FT NMR is not yet as sensitive a 
method as mass spectral analysis, we have demonstrated that it Is a 
viable analytical tool in the determination of microgram quantities of 
vitamin D metabolite structures. 
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SECTION II. 
24,26-DIHYDROXYVITAMIN D^ : A UNIQUE PHYSIOLOGICAL 
METABOLITE OF VITAMIN D^  
35 
INTRODUCTION 
The metabolism of vitamin has been extensively characterized 
and largely consists of oxidative modifications occurring in the side 
chain (1-8). The metabolism and biological activity of vitamin Dg are 
generally thought to parallel those of vitamin Dg, and as such, it is 
freely administered to both humans and commercially important mammals 
(9, 10). As a result, vitamin is prescribed for patients with a 
wide variety of vitamin D and calcium-related diseases. 
Inherent differences In vitamin metabolism from that of 
vitamin would appear to be Inevitable on the basis of its altered 
side chain structure. The presence of the C-22 alkene, coupled with 
the methylatlon of C-24, can be viewed as a barrier to normal oxidative 
processes known to occur in vitamin (11, 12). In human patients 
treated with phenobarbltone/phenytoln, the actions of vitamin and 
vitamin were seen to be quite different with respect to bone 
metabolism (13). In addition, the 25-hydroxyla8e activity in human 
liver exhibited different rates of mitochondrial hydroxylatlon for 
vitamin Dg and vitamin (14, 15). Consistent with these findings 
was the recent observation that other mammals such as the pig and rat 
discriminated between vitamin and vitamin (11). 
In conjunction with an ongoing study concerning the toxicity of 
vitamin D compounds, we now report the isolation and unequivocal 
identification of a unique vitamin metabolite, 24,26-(OH)202»^  
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This represents the first significant deviation of vitamin metabo­
lism from the more extensively characterized metabolism of vitamin D^ . 
A^bbreviations; 24,26-(0H)2D2, 24,26-dlhydroxyvltamln D^ ; 
24-OHD2, 24-hydroxyvltamln D^ ; 25-OHD2, 25-hydroxyvltamln D^ ; 24,25-
(0H)2D2, 24,25-dlhydroxyvltamln D2; 25,26-(0H)2Dg, 25,26-dlhydroxy-
vltamln D^ ; 25,26-(OH)2D2, 25,26-dlhydroxyvltamln Dg: GLC, gas-llquld 
chromatography; HPLC, high-performance liquid chromatography; GC-MS, 
gas chromatography-mass spectroscopy; NMR, nuclear magnetic resonance; 
PCC, pyrldlnlum chlorochromate; ICT, Intestinal calcium transport; 
BCR, bone calcium resorption. 
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MATERIALS AND METHODS 
General 
High-performance liquid chromatography (HPLC) was performed with 
Waters Associates ALC/GPC 204 liquid chromatographic equipment. HPLC 
columns were purchased from DuPont Instruments (Wilmington, DE). 
Zorbax-Sll refers to mlcropartlculate silica gel columns. Zorbax-ODS 
refers to the octadecasllane derivative of the mlcropartlculate silica 
gel columns. Zorbax-NHg refers to the 3-amlnopropyl triethoxy deriva­
tive of the mlcropartlculate silica gel columns. HPLC solvents were 
purchased from Burdlck and Jackson Laboratories (Muskegon, MI) or 
Fisher Scientific Company (Fair Lawn, NJ). Florlsll was purchased 
from Fisher Scientific Company. UV spectra were obtained in ethanol 
with a Beckman Model 25 recording spectrometer. Low-resolution mass 
spectra were obtained with solid probes by using a Finnlgan Model 4000 
Quadrupole GC-MS. The analyses were carried out at 70 eV with an 
ionizer temperature of 150*C while the probe was heated from ambient 
temperature to 350*C. High-resolution mass spectra were obtained with 
solid probes using a Kratos MS 50 GC-MS mass spectrometer. The 
300-MHz proton NMR spectra were taken in deuterated chloroform on a 
Nicolet NT-300 FT NMR spectrometer. Gas-liquid chromatographic 
analysis with flame ionization detection was carried out on a Hewlett 
Packard Model 5840A gas-liquid chromatograph. 
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Compounds 
Vitamin Dg was purchased from Sigma Chemical Co. (St. Louis, MO). 
Inhoffen-Lythgoe dlol was a gift from Dr. M. Uskokovlc (Hoffmann-La -
Roche, Nutley, NJ). Standard 25(R),26-(OH)2D2 and 25(S),26-(OH)2D2 
were gifts from Dr. D. Williams (University Chemical Laboratory, 
Cambridge, England). Deuterated chloroform (99.8 atom % D) and 
pyrldlnlum chlorochromate were purchased from Aldrlch Chemical Company 
(Milwaukee, WI). 
Isolation of Vitamin D2 Metabolites from Cow Plasma 
A Jersey cow was given weekly Intramuscular Injections of 1 g (40 
X 10^  units) of vitamin D2. After 4 weeks of treatment, blood was 
collected In heparlzlned containers. Plasma was prepared by centrl-
fugatlon and stored at -20°C. 
Vitamin D metabolites were extracted by using the following 
procedure. To 7 L of plasma was added 1400 g of ammonium sulfate. 
After shaking for 1 h, 8 L of acetonltrlle was added, and the mixture 
was shaken until an emulsion formed. The phases were separated by 
adding 2 L of methanol. The resulting mixture was filtered to remove 
the precipitated proteins, and the remaining pellet was reextracted 
with 5.4 L of acetonltrlle. Water (3 volumes) was added to the 
combined organic phases, and the mixture was applied to an 18 cm x 18 
cm CDS (Waters Associates, Milford, MA) equilibrated in 25% water in 
acetonltrlle. After the sample was applied to the column bed, 5 L of 
40% water in methanol was applied to elute the more polar lipids. The 
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vitamin D metabolites were then eluted by adding 8 L of acetonitrile. 
The acetonitrile was removed by vacuum, and the resultant lipids were 
dissolved in 2 mL of 2-propanol/methylene chloride/hexane (1:10:89). 
The dissolved lipids were applied to a Zorbax-Sil HPLC prep column 
(2.2 cm X 25 cm) and the vitamin D metabolites were eluted by use of a 
gradient of 2-propanol/methylene chloride/hexane (1:10:89 to 30:10:60). 
Metabolism and Biological Evaluation Studies 
Metabolites, including ZW-OHDg and 25-OHD2 for use in evaluation 
studies, were purified further using methods previously described 
(16). Initial experiments to study in vivo metabolism of various 
monohydroxylated vitamin Dg substrates were conducted using male 
weanling rats (Holtzman, Madison, WI) divided into four groups. Three 
of the groups were maintained on a vitamin D-deficient diet for 4 
weeks and then received daily oral supplements of 100 lU of either 
vitamin (group I) or vitamin (other two groups) for 3 weeks. 
During the last week of supplementation with vitamin one group of 
rats received daily intraperitoneal injections of 5 yg of 24-OHD2 
(group II) in 100 ml of propylene glycol carrier for 5 days, while the 
other group was similarly injected with 25-OHD2 (group III). The 
fourth group of rats (group IV) was maintained on a low-calcium 
(0.005%), vitamin D-deficient diet for 4 weeks, and then given intra­
peritoneal injections with 24-OHD2 as described. At the end of the 
treatment periods, blood was collected by cardiac puncture in hep-
arinized syringes and the plasma was frozen at -20°C. 
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Extraction of the plasma and Isolation of the vitamin Dg metabo­
lites was carried out as described previously (16, 17). 
Biological activity of vitamin Dg metabolites was determined with 
male weanling rats (Holtzman, Madison, WI) as described previously 
(18). 
Sllylatlon 
24,26-Dlhydroxyvltamln Dg (500 ng) was allowed to react with 
N-methyl-N-(trlmethylsllyl)trlfluoroacetamlde (50 pL) at 90*C for 2 h 
to effect persllylatlon. The mixture was dried under a stream of Ng 
and purified by reverse-phase HPLC. The sllylated product was eluted 
with 0.1% methylene chloride In methanol and analyzed by low-resolu-
tlon mass spectroscopy. 
Ozonolysls 
A solution of methylene chloride at -90"C was saturated with 
ozone, and the resultant blue solution was stored on dry ice. To the 
metabolite (2 yg) In 100 uL of pyridine at -90°C was added 100 yL of 
the methylene chloride/ozone solution. The mixture was kept at -90°C 
for 30 s and then dried at room temperature under a stream of Ng. The 
residue was dissolved In 10 yL of ethanol and analyzed by GLC using a 
2 mm X 10 ft 3% SP 2100 column employing Ng as carrier gas at a flow 
rate of 25 mL/mln. Temperature programming was as follows: 100*C/1 
min.; 10*C/mln.; 240*C/30 mln. The major product peak eluted at 12.75 
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min. at a temperature of 217°C. The low-resolution mass spectrum was 
obtained by 6C-MS. 
Oxidation of Inhoffen-Lythgoe Dlol 
The dlol (100 yg) was dissolved In 200 yL of methylene chloride 
to which 2 mg of FCC was added. The suspension was kept at room 
temperature for 20 mln with Intermittent vortexlng, and then 100 pL of 
2-propanol was added. The mixture was dried under a stream of 
The brown residue was dissolved In methylene chloride and then fil­
tered through a short column of Florlsll, and the column was washed 
with ether. The eluent was dried under a stream of to ca. 50 pL 
and analyzed by low-resolution GC-MS as described. 
Radioligand Binding Assay 
The comparison of the relative binding affinity of 24,26-(0H)2D2 
to other vitamin D metabolites for the rat plasma vitamin D binding 
protein was carried out as previously described (19). 
Plasma Assays 
Vitamin Dg and vitamin metabolite concentrations were assayed 
by HPLC or competitive protein binding as described by Horst et al. 
(17), or by radioimmunoassay as described by Mollis and Napoli (20). 
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RESULTS 
Because of the lack of commercially available vitamin Dg metabo­
lites, plasma from a cow Intoxicated with vitamin Dg was used In 
anticipation of Isolating large quantities of 25-OHD2, 24,25-(OH)2D2> 
and 25,26-(0H)2D2 for use as laboratory standards. During the isola­
tion and identification procedures, we observed that the metabolite 
tentatively identified (because of its HPLC migration character; 16) 
as 25,26-(0H)2D2 reacted unpredictably In several Independent identi­
fication procedures. Most notable were the insensltlvity of the 
metabolite to periodate (data not shown) and an uncharacteristic mass 
spectrum. Subsequently, more extensive Identification techniques were 
employed to positively Identify the new metabolite. 
The metabolite, purified from cow plasma, displayed a UV absorb-
ance spectrum characteristic of a 5(E),7,10(19)-triene chromophore 
(not shown). The absorbànce maximum was at 265 nm, and the absorbance 
minimum was at 229 nm. On the basis of the absorbance spectrum, 
approximately 80 yg of the metabolite was isolated from the bovine 
source. 
An insufficient amount of metabolite was Isolated from rat plasma 
for identification. However, the metabolite isolated from the rat 
plasma comlgrated with the bovine compound on two different HPLC 
systems. Comigration was observed on a Zorbax-Sll column developed in 
methanol/2-propanol/methylene chloride/hexane (0.75:2.5:25:72, peak 
elutes at 24-28 mL), and a Zorbax-NHg column developed in methanol/2-
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propanol/hexane (1:3:96, peak elutes at 40-44 mL). The comlgratlon on 
two chemically distinct HPLC systems verified that the material 
Isolated from the bovine and rat sources was Identical (16). The 
mobility of this new metabolite relative to several known vitamin D 
compounds on a Zorbax-Sll column developed In methanol/aceto-
nltrlle/methylene chloride (1:20:180) Is shown In Figure 1. 
The high resolution mass spectrum of the metabolite (Figure 2) 
had a molecular Ion at m/z 428.3286 Indicating an elemental composi­
tion of (calculated value of 428.3290). This molecular 
formula was consistent with a dlhydroxylated vitamin Dg metabolite. 
The peaks at m/z 410 (M-18) and 395 (M-33) can be attributed to 
sequential losses of water and a methyl group. The characteristically 
large peaks at m/z 136 and 118 demonstrated that the trlene system 
remained Intact and ruled out A-ring substitutions. The peaks at m/z 
271 and 253 arise from the cleavage of the steroid side chain and 
subsequent loss of water. This Indicated that the two remaining 
hydroxyl groups were a part of the side chain. Absence of either a 
significant M-58 peak or a peak at 59 amu, often seen in 25-hydroxy-
lated vitamin Dg compounds, discounted the presence of a 25-hydroxyl 
group in the metabolite (16). The peak at m/z 380.3075 (M-48) had an 
elemental composition of C^ yH^ QO (calculated value of 380.3079) 
representing an unusual loss of CH^ Og from the molecular ion. An 
even-numbered loss of this type strongly suggests a rearrangement. 
The elimination of 48 amu from the parent ion may arise from an 
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Flgure 1. Comparison of the relative mobility of 24,26-(0H)2D2 with 
various vitamin D metabolites on a Zorbax-Sil column 
developed in methanol/acetonitrile/methylene chloride 
(1:20:180) 
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Figure 2. High-resolution mass spectrum of 24,26-(0H)2D2 Isolated 
from bovine plasma 
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Intramolecular proton transfer involving both the C-24 and C-26 
hydroxyl functions. This would result in the elimination of water and 
formaldehyde molecules (C-26) from the molecular Ion. 
Persilylation of the metabolite produced a compound with a 
molecular ion at m/z 644, which established that three alcohol groups 
were present (Figure 3). The peaks at m/z 554 and 464 represented the 
successive losses of (CHg)2SiOH from the parent ion. More significant 
was the peak at m/z 513. This corresponded to a loss of 
CH^ CHCH^ OS 1(0112)2 from the terminus of the side chain as a result of 
0-cleavage of the silyl ether present at C-24. This also accounted 
for the peak seen at m/z 131. Cleavage of the side chain resulted in 
the peak observed at m/z 343. The peak at m/z 333 represented the 
combined losses of two (CHg)gSiOH functions in addition to the previ­
ously discussed loss of 131 amu from the molecular ion. 
The major product obtained from ozonolysls of the metabolite was 
characterized by GC-MS (Figure 4). The low resolution mass spectrum 
indicated a parent ion at m/z 208. This corresponded to cleavage of 
the C-7/C-8 and C-22/C-23 olefin bonds. Losses of water (M-18) and a 
methyl group (M-15) were readily evident. In addition, cleavage of 
N* 11*-48 
47 
ira 
:.|i 
(OH,), SIC' 
28# 
iuLiu 
 ^w » 
yUiLi 
644 
100 200 300 400 500 600 
M / Z  
Figure 3. Mass spectrum of the trimethylsllyl ether derivative of 
24,26-(0H)2D2 
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Figure 4. Comparison of GC-MS of the major product obtained from 
the ozonolysls of 24,26-(0H)2D2 (upper spectrum) and 
the product obtained from the oxidation of Lythgoe-
Inhoffen dlol (lower spectrum) 
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the side chain accounts for the peak at m/z 151. The mass spectrum of 
the ozonolysls product was In excellent agreement with the product 
obtained from oxidation of Inhoffen-Lythgoe dlol. This placed the 
alcohol groups In the terminal portion of the side chain. 
A 300-MHz NMR spectrum was taken of 40 yg of the metabolite 
(Figure 5). The signals at 66.31, 6.02, 5.03, and 4.81 indicated 
that the characteristic trlene system was Intact. These peak posi­
tions also confirmed the lack of lo-hydroxylatlon in the metabolite. 
The multiplet corresponding to the C-22/C-23 oleflnic protons was 
located at 65.48. The downfleld shift of this multiplet, relative to 
that observed in vitamin Dg, was taken as further evidence of hydroxy-
latlon at C-24. The signal at 63.94 (1 H) represented the 3a-proton 
and confirmed,the presence of the 36-hydroxyl group. The multiplet at 
63.66 (2 H) can be attributed to the presence of the C-26 hydroxyl 
group. The singlet at 60.56 (3 H) and the doublet at 61.05 (3 H, J = 
6.6 Hz) were consistent for the C-18 and C-21 methyl groups. A lone 
doublet located at 60.81 (3 H, J • 6.9 Hz) corresponded to the C-27 
methyl group. The observed splitting pattern further confirmed the 
absence of substitution at C-25. The C-28 methyl group appeared as a 
singlet at 61.30 and is consistent for C-24 hydroxylation in vitamin 
Dg compounds (21). 
The affinity of 24,26-(OH)2D2 for the rat plasma vitamin D 
binding protein relative to other vitamin D metabolites is presented 
In Table 1. The metabolites were assessed for their abllitiy to 
3 displace [ H]-25-0HDg from the 4.2S rat plasma vitamin D binding 
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Figure 5. The 300-MHz NMR spectrum of 40 yg of 24,26-(0H)2D2. 
The insert is an expanded view of the upfield portion of 
the spectrum 
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Table 1. Ability of vitamin D metabolites to displace [®H]-25-0HD3 
from the rat plasma vitamin D binding protein 
Metabolite 
Amount that 
produces 50% 
displacement of 
[»H]-25-0HD3 (ng) 
Competitive 
Index 
relative to 
25-OHD3® 
25-OHD2 0.6 100 
25-OHD3 0.6 100 
24(R)-25-(0H)2DS 0.6 100 
24(R)-25-(0H)2D2 1.2 50 
24,26-(0H)2Da 2.0 30 
®The amount of 25-OHD3 that displaces 50% of the [®H]-25-0HD3 
divided by the amount of metabolite that will displace 50% of the 
[®H]-25-0HD3 times 100. 
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protein. Approximately 3.3 times more 24,26-(OH)2D2 was needed to 
achieve 50% displacement than either 25-OHD or 24(R),25-(0H)2Dg. The 
24(R),25-(0H)2D2 exhibited a higher affinity for the binding protein 
than 24,26-(0H)2D2 in this assay, but was twofold less potent than Its 
vitamin analog. 
The ICT and BCR responses of rats dosed with various amounts of 
test compound are presented In Table 2. The data indicated that 
24,26-(0H)2D2 has little, If any, effect on ICT and BCR despite 
Increasing the dose up to 200 ng/rat. In contrast, the administration 
of a minimal dose (50 ng/rat) of was seen to significantly 
increase both ICT and BCR. 
Significant quantities of 24,26-(OH)2D2 were detected in the 
plasma of both rats given vitamin Dg as their sole source of vitamin D 
and a cow treated with a large amount of vitamin Dg (Table 3). When 
rats received 24-OHD2, in addition to a vitamin supplement, 24,26-
(0H)2D2 was present in a 4-fold higher concentration than 24,25-(OH)2D2 
(group II). The concentration of 24,26-(0H)2D2 was diminished and 
only slightly higher than that of 24,25(OH)2D2 when 24-OHD2 was 
administered to rats maintained on a low calcium, vitamin D-deficient 
diet (group IV). No metabolites comlgrating with 24,26-(OH)2D2 were 
detected in vitamin Dg-supplemented rats given 25-OHD2 (group III). 
Rats supplemented with 25-OHD2, however, possessed a greatly elevated 
concentration of 24,25-(0H)2D2 in their plasma. 
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Table 2. Biological evaluation of 24,26-(0H)2Dg using the rat 
bloassay 
Compounds Dose '^ C^a(serosal)/ Plasma Ca 
given (ng/rat) "^ C^a^ mucosal) (mg/dL) 
24,26-(OH)aD2 50 1.3 ± 0.1 5.6 ± 0.1 
24,26-(0H)2D2 100 1.5 ± 0.1 5.6 ± 0.2 
24,26-(OH)2D2 200 1.3 ± 0.1 5.3 ± 0.1 
25-OHD2 50 2.4 ± 0.1® 6.0 ± 0.2® 
Control 1.4 ± 0.1 5.4 ± 0.2 
*ICT, intestinal calcium transport. 
B^CR, bone calcium resorption. 
D^iffers from control at p < 0.05. 
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Table 3. Plasma concentrations of vitamin D metabolites In 
treated rats 
ng/mL 
24,25- 24,25- 24,26-
Treatment (group) (OH^ gDg (OH^ gDa) (OHÔgDg 
Da® (I) ND^  4.1 + 2.3 1.7 ± 1.0 
Ds® +24-0HD2° (II) 3.3 ± O.l 3.3 ± 0.3 14.3 ± 6.9 
Ds*. +25-080:^  (III) 2.8 ± 0.8 93 ± 18 ND 
-Ca, -D, +24-OHD2® (IV) ND 4.9 ± 0
 
CO
 
5.9 ± 0.4 
Excess vitamin Dg (cow) 3.5 ± 1.1 106 ± 36 14.7 ± 8.8 
*Oral supplement of 100 lU/day. 
N^ot detected. 
I^ntraperitoneal Injection of 5 yg/day for 5 days. 
DISCUSSION 
This paper reports the.identification of a new vitamin metabo­
lite as 24,26-(0H)2D2. Several independent techniques were employed 
to characterize the metabolite; however, the mass spectrum was remark­
able for the presence of a peak at m/z 380 indicative of a rearrange­
ment of the parent ion. Similar types of rearrangements can be 
observed in the mass spectra of other 1,3-diols of vitamin D metabo­
lites (4, 7). The identification of the metabolite was greatly 
facilitated by our ability to obtain a high-resolution NMR spectrum 
of the material. A conventional interpretation of the NMR data, 
whereby the C-21 and C-24 methyl group protons have been assigned to 
the signals at 50.90 and 1.01, would have suggested the metabolite's 
structure as 20,26-(OH)2^ 2. However, from the ozonolysis work already 
discussed, as well as a recent NMR study on vitamin Dg metabolites by 
Koszewski et al. (21), the C-24 and not the C-20 position has been 
hydroxylated. 
The 24,26-(0H)2D2 isolated in this study exhibited a lower 
affinity for the rat plasma vitamin D binding protein than 25-OHD. 
Hydroxylatlon at C-26 evidently results in yet a further decrease of a 
24-hydroxylated vitamin Dg metabolite's affinity for the binding 
protein as seen in the lower competitive index of 24,26-(0H)2D2 
relative to 24(R),25-(OH)2D2. 
The ability of 24,26-(0H)2D2 to stimulate Intestinal calcium 
transport or bone calcium resorption, as measured in our assays, was 
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Insignificant. Horst et al. have previously demonstrated that ZA-OHDg 
possesses significant biological activity, most likely as a result of 
its ability to be lo-hydroxylated (22). Evidently, the formation of 
24,26-(0H)2D2 represents a pathway for the deactivation of 24-OHD2. A 
comparable situation exists with regard to vitamin metabolism, in 
that C-26 hydroxylation seemingly represents a means of rendering 
25-OHDg biologically inactive (23). 
Collectively, the data from our controlled rat studies demon­
strated that the preferred metabolic pathway for the metabolism of 
ZA-OHDg under physiologic conditions is the biosynthesis of 24,26-
(OHOgDg (Table 3). Our data further show that 24-OHD2 is a poor 
substrate for the production of 24,25-(0H)2D2, with 25-OHD2 being the 
preferred precursor. The low plasma concentration of 24,26-(0H)2D2 
under conditions of vitamin D deficiency and low calcium probably Is a 
result of the channeling of 24-OHD2, the sole dietary source of 
vitamin D in this experiment, to its biologically active la-hydroxy-
lated derivative (22). C-26 hydroxylation would be predicted to be 
attenuated considerably under these dietary conditions. 
Also noteworthy is the observed lack of 25,26-(OH)2D2 production 
in rats given 25-OHD2 (data not shown). Consistent with this observa­
tion was our demonstration that 25,26-(OH)2D2 was not detectable in 
the plasma of a vitamin D2 intoxicated cow. The only vitamin D2 
metabolite migrating in the 25,26-(OH)2D2 region of the prep HPLC 
column used in these experiments was 24,26-(OH)2D2. 26-Hydroxylatlon 
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of ZS-OHDg evidently represents a relatively Inefficient process 
relative to the 26-hydroxylation of ZA-OHDg or 25-OHDg. 
Figure 6 summarizes the metabolic pathways Involved in the side 
chain hydroxylations of vitamin in animals receiving normal dietary 
calcium and vitamin Dg. Vitamin Dg is preferentially hydroxylated at 
the 25-position with C-24 oxidation present as a minor pathway. A 
major route of ZS-OHDg metabolism results In the production of 24,25-
(0H)2D2. On the other hand, only a small amount of 24-OHD2 is metabo­
lized to 24,25-(OH)2D2 with hydroxylation at C-26 to yield 24,26-
(0H)2D2 being the major metabolic pathway. This data may aid In 
explaining differences in biological activity and toxicity known to 
exist between vitamin Dg and vitamin and represent the first 
significant deviation of vitamin Dg metabolism from that of vitamin 
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Figure 6. Preferred pathways of side-chain oxidations in the 
metabolism of vitamin Dg under conditions of normal 
vitamin supplementation 
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SECTION III. 
THE EFFECT OF AGE ON THE 1,25-DIHYDROXYVITAMIN Dg 
STEROID RECEPTOR IN MALE FISCHER 344 RATS 
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INTRODUCTION 
Vitamin Dg, a seco-steroid, is produced In the skin by a process 
initiated by the direct action of sunlight on a cholesterol precursor. 
The vitamin then undergoes a series of tissue-specific hydroxylations 
resulting in production of what Is generally regarded as the active 
hormonal form of the vitamin, 1,25-(0H)2D2^  (1, 2). The primary role 
of l,25-(0H)2Dg has been characterized as the maintenance of calcium 
homeostasis with primary target tissues being the intestine, kidney, 
and bone. Typical of other steroid hormones, 1,25-(OH)20^  Interacts 
with an intracellular receptor protein in target tissues (3-5). This 
complex Is then thought to bind to specific sequences of DNA (termed 
vitamin D response elements, VDRE) resulting in the alteration of 
transcriptional events. One such event that has been characterized 
has been an Increase in the synthesis of an intracellular calcium-
binding protein In intestinal tissue (6, 7). 
Age-related differences in steroid receptors have generated in­
creased research interest. Sharma and Tlmlras, in examining the gluco­
corticoid receptor in the livers of Long-Evans male rats, determined 
that weanling rats possessed a significantly higher number of 
A^bbreviations used: l,25-(0H)2Dg, 1,25-dlhydroxyvltamin D^ ; 
24,25-(0H)2Dg, 24,25-dlhydroxyvltamin D^ ; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamlde gel electrophoresis; DCC, dextran-coated char­
coal; CIM, Carnation Instant nonfat dry milk. 
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specific binding sites relative to nature (26 weeks) animals (8). Lu 
et al. examined developmental changes of glucocorticoid receptors In 
the pancreata of Sprague-Dawley rats. Binding capacities were found 
to be low in 1-day-old pups accompanied by an increase to maximal lev­
els at weaning, followed by a decline in specific binding as the ani­
mals aged (9). A recent report indicated that the ability of uterine 
estrogen receptors from aged mice to bind non-speciflcally to DNA-
cellulose was only one-half that of young animals (10). This work 
implied the presence of an endogenous inhibitor that prevented binding 
to nuclear acceptor sites, particularly in aged animals. 
A number of studies have examined the appearance of the vitamin D 
receptor in embryonic tissues and neonatal animals (11-13), but far 
less is known concerning the characteristics of the receptor as an 
animal reaches maturity and progresses into old age. Changes in either 
receptor number or in the protein Itself may have profound consequences 
In the ability of an animal to respond to the active hormone. The 
ability to absorb calcium from the Intestine is known to decrease with 
age in various species (14-17). Much of this work has focused on the 
impaired ability of aged animals to convert 25-OHDg to 1,25-(OH)20^  In 
the kidney (18-22). The lower circulating hormone concentrations 
present In older animals would Imply diminished interaction with re­
ceptors In target tissues. Yet, exogenously administered 1,25-(OH)20^  
to young and aged rats has, at least in one instance, failed to exhibit 
an Increase of comparable magnitude in calcium absorption in the aged 
animals (23). In addition, several reports have recently appeared 
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concerning the differences In the vitamin D receptor number and occu­
pancy of young and aged male rats (24-26). These preliminary studies 
described a marked decrease In receptor number In mature animals both 
in Intestinal and bone tissue when measured against weanlings. These 
latter observations provide a basis for further research to determine 
If a relationship exists between receptor number and the known Impaired 
ability of an aged animal to absorb calcium from the Intestine. 
The purpose of the present study was to examine both the Intesti­
nal and kidney receptor for vitamin D at two different stages of de­
velopment In male Fischer 344 rats. This work quantified total unoc­
cupied receptor numbers» and the ability of the various receptor 
preparations to bind non-speclflcally to DNA-cellulose. Immunoblots 
of receptor preparations were also examined to detect possible changes 
In protein size. In addition, plasma concentrations of l,25-(0H)2Dg 
and calcium were determined for differences In the two age groups. 
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MATERIALS AND METHODS 
General 
Hydroxyapatlte was purchased from Blo-Rad Laboratories (Richmond, 
CA). Soybean trypsin Inhibitor was obtained from Sigma Chemical Corp. 
(St. Louis, MO). Trayslol was purchased from Mobay Chemical Corp. 
(New York, NY). DNA-Cellulose was prepared according to the procedure 
of Llttman (27) using calf thymus DNA (Sigma) and Whatman CF-11 cellu­
lose (W & R Balston, Ltd., England). l,25-(0H)2Dg and 24,25-(CH)2D2 
were gifts from Dr. M. R. Uskokovlc of Hoffmann-La Roche (Nutley, NJ). 
3 [ H]-l,25-(0H)2Dg (90 Cl/mmol) was synthesized as previously described 
(28). High-performance liquid chromatography was carried out with 
Waters Model ALC/GPC 204 liquid chromatography equipment (Waters Asso­
ciates, Mllford, MA). Gel filtration HPLC analysis was performed by 
using a Spherogel TSK 3000 SW column (0.75 x 60 cm, Beckman Instru­
ments Inc., Berkeley, CA). The 9A7y monoclonal antibody directed 
against the vitamin D receptor was a gift from Dr. J. W. Pike, Baylor 
College of Medicine (Houston, TX). Rabblt-antl-rat IgG (H+L, mouse 
serum absorbed) was obtained from Zymed Laboratories (So. San Fran­
cisco, CA). Proteins were electrophoretlcally transferred to Gene 
Screen hybridization membranes (NEN Research Products, Boston, MA). 
Electrophoretlcally pure reagents. Protein A gold colloid, and silver 
enhancement kit were obtained from Blo-Rad Laboratories. The KTD 
buffer utilized throughout these studies contained 10 mM Trls-HCl, pH 
7.4 (at 4*C), 5 mM dlthlothreltol, and the Indicated concentration of 
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potassium chloride (I.e. KTD-500 contains 0.5 M KCl). Protein was 
assayed by the method of Bradford (29). Concentrations of potassium 
and plasma calcium were determined using a Perkln Elmer Model 5000 AÂ 
spectrophotometer at wavelengths of 404.7 nm and 422.7 nm, respec­
tively. 
Animals 
Barrier-derived young (1 mo) and aged (18 mo) male Fischer 344 
rats were obtained from the National Institute on Aging. The animals 
were maintained on a normal rat chow diet (Teklad 4%), and were al­
lowed to acclimate to their environment for at least 1 week prior to 
their use. 
Receptor Preparation 
The first 20 cm of small Intestine were removed and flushed with 
Ice-cold Trls-buffered saline containing Trayslol (50 KlU/ml). All 
subsequent steps were performed at ca. 4°C. The mucosa was scraped 
free and a 20% homogenate prepared In KTD-500/sbtl (100 yg/ml) using a 
Polytron tissue homogenlzer. The homogenate was spun In an ultracen­
trifuge at 230,000 g for 30 mln to yield a supernatant containing 
buffer-soluble cellular components (termed cytosol). Kidney prepara­
tions were similar to that described above. 
Receptor Assays 
Unoccupied receptor concentrations were obtained by labelling 
3 
subsamples of the cytosol In 24 nM t H]-1,25-(0H)2D2 ± a 200-fold 
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excess of cold steroid at 4°C for 2-3 h. A 4-fold excess of 24,25-
(OHOgDg was also added to all tubes to minimize Interference from the 
vitamin D binding protein. The samples were stripped with 1% dextran-
coated charcoal and the receptor-hormone complexes were quantltated by 
hydroxyapatlte In triplicate (30). The percentage of binding to DNÂ 
was determined by using allquots of the labelled cytosol samples 
described above, also In triplicate. Following the charcoal strip, 
the hormone-receptor complexes were Incubated with 500 yl of 50:50 
slurry of DNA-cellulose in TD buffer in a final volume of 1 ml at a 
[K*] approximating 150 mM. After 45 mln with occasional gentle vor-
texlng, the cellulose was pelleted and washed 2x with TED buffer (1 mM 
EDTA) containing 0.5% Triton X-100. The pellets were then extracted 
2x with 1.5 ml of absolute EtOH; the samples were dried and counted 
for radioactivity. 
DNA-Cellulose Chromatography 
Cytosol was labelled in 5-7 nM [^ H]-l,25-(0H)2Dg with a 4-fold 
excess of 24,25-(OH)as described above. A 50:50 slurry of DNA-
cellulose in TD buffer was added to the cytosol to yield an approxi­
mate [K*] of 150 mM. After mixing intermittently for 1 h, the slurry 
was poured into a 1.5 cm diameter column. The column was washed at a 
flow rate of ca. 40 ml/h with 20-30 volumes of KTD-100 buffer, followed 
by a linear gradient from TED to KTED-500 (1 mM EDTA). Then 100 jjl 
allquots were removed from the collected fractions (ca. 3 ml/fraction) 
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and counted for radioactivity to trace hormone-receptor binding. Sam­
ples of receptor-hormone complex were precipitated with either 40% or 
70% saturated ammonium sulfate and analyzed in immunoblots. Alterna­
tively, receptor could be precipitated with 8% trichloroacetic acid. 
Receptor-Antibody Complexes 
Cytosol was incubated in 5-7 nM labelled steroid as above. Fol­
lowing a 1% DCC strip, 25 ng of receptor (as determined by hydroxy-
apatite assay) was mixed with 100 yl of diluted 9A7y monoclonal anti­
body for 6 h at 4*C in a final volume of 400 ul at a [K*] of 200 mM. 
Preparations were then analyzed via HPLC chromatography. 
HPLC Analysis 
The chromatography was carried out as previously described with 
the following modifications (31). The analysis was determined at 4°C. 
The Spherogel-TSK 3000 SW column was equilibrated in a buffer comprised 
of 20 mM sodium phosphate (pH 7.3), 1 mM EDTA, 2 mM DTT, 200 mM KCl, 
1% glycerol, and 0.1% Tween 20. A flow rate of 1 ml/min was employed 
and fractions were collected collected every minute. Collected 
fractions were counted for radioactivity to trace the elutlon profile 
of the hormone-receptor complex. 
Immunoblot Analysis 
Protein samples were obtained from DNA-cellulose chromatography 
that had been either precipitated with ammonium sulfate (40% or 70%), 
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or with trichloroacetic acid (8%). The pelleted proteins In all cases 
were denatured in SDS-PA6E reducing buffer and resolved on 12% 
SDS-polyacrylamide gels according to the method of Laemmll (32). Pro­
teins were electrophoretlcally transferred to Gene Scree hybridization 
membrane. Transfer was carried out at 100 V for 1 h by using a 
transfer buffer (0.025 M Tris-HCl, 0.19 M glycine) containing 0.1% 
SDS. Following the transfer, the membranes were subjected to 
immunoblot analysis as follows. The membranes were suspended for 1 h 
in phosphate-buffered saline (PBS, 10 mM sodium phosphate, pH 7.2, 
0.9% NaCl) containing 10% CIM. The membranes were then transferred to 
a solution of PBS/10% CIM containing a 1:2000 dilution of 9â7y mono­
clonal antibody and Incubated overnite at 4*C. The membrane was 
washed for 30 min in PBS containing 0.3% Tween 20 with two changes of 
buffer. After a 1-h incubation of the membrane in PBS/10% CIM, the 
membrane was suspended overnite at A'C in a solution of PBS/10% CIM 
containing a 1:5000 dilution of rabbit-anti-rat antiserum. Following 
the previously described wash procedure, the membrane was Incubated 
for 4 h in Protein A gold colloid. The membrane was washed for 30 min 
in PBS, 0.3% Tween 20 with two buffer changes. Color enhancement of 
immunoblotted proteins was accomplished with silver lactate. Non­
specific bands were accounted for by the omission of the monoclonal 
antibody incubation in the above steps. 
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1,25-(OH)2DJ Assay 
Plasma concentrations of 1,25-(OH)20^  were determined as previ­
ously described (33). 
Statistics 
The tabularlzed data from these experiments are reported as the 
mean ± SEM along with the number of animals In the determination. 
Statistical analyses were performed by using Student's _t test and a 
confidence level of 95% or greater was considered significant. 
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RESULTS 
Plasma was collected from both young and aged rats, and assayed 
for calcium and l,25-(0H)2Dg concentrations (Table 1). In both cases 
the aged Fischer rats possessed significantly lower plasma concentra­
tions than their younger counterparts. 
The results from an assessment of unoccupied intestinal receptor 
status for young and aged animals are presented In Table 2. An Ini­
tial inspection of the data Indicated that there were no differences 
in the receptor concentrations for young and aged animals. When the 
data, however, were examined as a function of time following the arri­
val of the animals to the facility, the aged animals could be placed 
into two categories: 1) those experiments conducted within the first 
28 days of arrival and 2) those that were carried out 29+ days after 
arrival. Aged animals within the first period possessed receptor con­
centrations in excess of 500 fmol/mg protein, whereas those from the 
second time period had only one-half the concentration as the former 
group. Young animals exhibited no time-dependent difference in recep­
tor concentrations and remained elevated throughout the experiments. 
In addition, the young rats possessed significantly higher receptor 
concentrations than did the aged animals during the second time 
period. 
The percent DNA binding was not significantly different for the 
young and aged intestinal receptor preparations (Table 2). Aged 
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Table 1. Concentrations of calcium and 1,25-(OH)2^ 3 In the 
plasma of young and aged Fischer 344 rats 
Young Aged 
,.a 
Ca^  10.6 ± 0.1 (12)® 9.7 ± 0.2 (13) 
1,25-(0H)2D3^  102.2 ± 14.1 (12) 33.1 ± 5.7 (13) 
C^oncentration as mg/dl. 
C^oncentration as pg/ml. 
®The number in parentheses refers to the number of 
animals examined in determining the average value ± SEM. 
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Table 2. Properties of intestinal 1,25-(0H)2D3 receptor 
prepared from young and aged Fischer 344 rats 
Young Aged 
Unoccupied* 446 ± 26 (14)C 368 ± 53 (12) 
7-28 days^  435 ± 33 (8) 525 ± 52 (5) 
29+ days 461 ± 44 (6) 254 ± 39 (7) 
% DNA binding 55.8 ± 3.0 (14) 51.2 ± 2.9 (12) 
E^xpressed as fmol/mg protein. 
D^ays following arrival to the laboratory. 
T^he number In parentheses refers to the number of animals 
examined In determining the average value ± SEM. 
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animals exhibited no differences during the two projected time periods 
despite a significant decline In receptor concentration. 
Kidney receptor concentrations were lower relative to Intestine 
for both young and aged rats (Table 3). There was, however, no mea­
surable difference In receptor concentration between the two groups. 
An Insufficient number of aged rats were analyzed during the early 
period described above to ascertain If a time-dependent decline oc­
curred In kidney receptor concentrations. Receptor cytosols from aged 
rats. In contrast, displayed a marked decrease In their ability to 
bind to DNA-cellulose relative to samples from young rats (ca. 24% 
versus 44%). 
Figure 1 shows typical DNA-cellulose column chromatography pro­
files for both young and aged Intestinal preparations. In both cases 
the receptor-hormone complex was eluted from the column at approxi­
mately 240 mM potassium concentration. DNA-cellulose chromatography 
profiles of young and aged kidney preparations are presented in 
Figure 2. There is a decline in the amount of specifically bound 
receptor relative to that seen in the Intestinal preparations, and the 
peak breadth was observed to be greater in the kidney preparations. 
Indeed, kidney preparations from particularly young animals occasion­
ally appeared as a poorly resolved doublet (Figure 2). 
When Intestinal receptor fractions were pooled following DNA-
cellulose chromatography and fractionated with 40% ammonium sulfate, 
normally 70-80% of the radiolabelled material would precipitate in the 
case of receptor prepared from a young rat. Employing the same 
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Table 3. Properties of kidney 1,25-(0H)2D3 receptors prepared 
from young and aged Fischer 344 rats 
Young Aged 
Unoccupied* 149 ± 8 (8)^  155 ± 8 (8) 
% DNA binding 43.6 ± 3.9 (8) 24.1 ± 2.3 (8) 
E^xpressed fmol/mg protein. 
T^he number In parentheses refers to the number of animals 
examined In determining the average value ± SEM. 
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Figure 1. Representative DNA-cellulose column chromatography profiles 
of Intestinal receptor preparations from young (upper panel) 
and aged (lower panel) rats. Receptor was eluted by using a 
KCl gradient. Allquots (100 pi) were removed from collected 
fractions (3 ml) and counted to trace the hormone-receptor 
complex 
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Figure 2. Typical DNA-cellulose chromatography profiles of kidney 
receptor prepared from young and aged rats. Receptor 
from the young rats was eluted as a poorly resolved 
doublet, Implying receptor forms with different affinities 
for DNA 
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conditions with Intestinal receptor from aged rats typically resulted 
In the precipitation of only 20-30% of the radlolabelled material. 
Thus, 70% saturation with ammonium sulfate was used to Insure that the 
majority of the radlolabel (I.e., hormone-receptor complex) was pre­
cipitated. 
Representative Immunoblots of young and aged receptor prepara­
tions following DNA-cellulose column chromatography and ammonium sul­
fate precipitation (70%) are presented In Figure 3. Young Intestinal 
receptor is visible as a single band at approximately 52K (lane A). 
The aged intestinal receptor preparation was not detected In an appre­
ciable manner in the immunoblot analysis (lane B), despite loading an 
equivalent amount of receptor (based on pooled column collections). A 
lower molecular weight band (ca. 24K) Was present In the aged intes­
tinal preparation which was absent in the young sample (lane B versus 
lane A), and most likely represents a proteolysis product. The mixing 
of young and aged intestinal receptor resulted In the dimlnlshment of 
the 52K receptor band, and concomitant appearance of several lower 
molecular weight bands (lane D). Receptor from the young rat alone 
was still clearly visible at 52K, together with a single low molecular 
weight band. Note that lane D contains an equivalent amount of young 
receptor from the same preparation as in lane C, but which had been 
mixed and incubated overnight with post-column receptor obtained from 
an aged animal. The aged and young kidney receptors appear as a pair 
of bands at approximately 52K and 50K (lanes E and F). The higher 
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Figure 3. Immunoblot analysis of vitamin D receptor preparations 
following DNA-cellulose column chromatography. Lane A, 
young Intestine; lane B, aged Intestine; lane C, young 
Intestine control for the mixed receptor experiment; 
lane D, mixed young and aged Intestine; lane E, young 
kidney; lane F, aged kidney 
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molecular weight band from kidney preparations co-migrates with the 
Intestinal receptor preparations In this system (data not shown). 
Gel filtration HPLC analysis was performed on both young and aged 
Intestinal cytosol preparations (Figure 4). Equivalent amounts of 
receptor (25 ng) were allowed to Interact with varying dilutions of 
9A7Y monoclonal antibody. The analysis Indicated that the receptor 
from both the young and aged Intestine was shifted to a higher molecu­
lar weight species In an Identical fashion at equivalent dilutions of 
the antibody. 
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Figure 4. Gel filtration HFLC analysis of the affinity of monoclonal 
9A7Y for young and aged receptor in cytosol preparations. 
Hormone-labelled receptor (25 ng) was incubated with the 
appropriate dilutions of antibody for 6 h at 4"C prior 
to chromatography 
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DISCUSSION 
The evaluation of unoccupied Intestinal receptor concentrations 
from young and aged rats Indicated that there is an apparent time-
dependent decline in the receptor concentration of aged animals, 
whereas no such event was detected in receptor prepared from young 
rats. There are a number of possibilities that may account for this 
phenomenon. The stress associated with cross-country shipment (Indi­
anapolis, IN to Ames, lA) and acclimation to a new environment, re­
sulting in Increased plasma concentrations of glucocorticoids, may 
have a greater impact on aged rats. Glucocorticoids are known up-
regulators of the l,25-(0H)2Dg receptor (34, 35). As a corollary to 
the explanation given above, these animals were maintained under bar­
rier conditions and were pathogen-free prior to shipment. Some of the 
aged rats, particularly with regards to the first group studied in our 
laboratory, displayed signs of Illness, including red mattery eyes and 
a listless behavior when approached. Attempts to identify a pathogen 
from cultures of lung tissue were inconclusive. Cross-country 
shipment may have made the aged rats more susceptible to opportunistic 
infection, resulting in, again, an increase in circulating plasma 
glucocorticoids with a subsequent Increase In l^ ZS-ZOHjgDg steroid 
receptor concentrations. Assaying the plasma for the concentration of 
corticosterone would be a means of testing these possibilities. None 
of the younger animals developed any clinical signs of Illness 
throughout the time periods Involved. 
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A comparison of the diet administered prior to shipment (Teklad 
NIH31) and that fed In these experiments (Teklad 4%) reveals the fol­
lowing. There was ample calcium, phosphorus and vitamin D In both 
diets. The Teklad 4% diet, however, had a higher percentage of cal­
cium In the diet (2% versus 1%) with a concomitant Increase In the 
calclum-to-phosphorus ratio. The relatively high calcium content of 
the diet may have lessened the need for active transport of calcium 
from the gut, resulting In the decline In intestinal receptor numbers 
with time In aged rats. No perceptible decrease In Intestinal recep­
tor number for young rats was detected, but these were growing animals 
with a large demand for calcium and receptor numbers may remain ele­
vated. In either diet, however, the necessary requirements for growth 
and maintenance are more than met (36). Thus, It Is not entirely clear 
why the Intestinal receptor numbers from aged rats would Initially 
appear so high. 
Finally, It has been previously noted that Fischer 344 rats under­
go marked physiological changes at approximately 18 months of age, 
including an Increase in number of observed lesions and neoplasms (37). 
It is possible that our studies may have simply coincided with these 
physiological changes, and that receptor concentrations remain osten­
sibly elevated up to this point. An examination of animals from ear­
lier ages would be useful to answer this issue. 
At this time, it would seem most appropriate to limit the discus­
sion to animals that had the 4-week period to acclimate to their sur­
roundings. In this case, there is a significant decrease in the 
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number of unoccupied receptors. Similar observations have been made 
In the Holtzman rat with regard to the 1,25-(OH)steroid receptor 
(24, 25). The decrease In receptor number combined with the observed 
lower plasma concentrations of l,25-(0H)2Dg is consistent with the 
known impaired ability of aged rats to absorb calcium in the intestine 
(15, 23). Decreased receptor numbers as a function of increasing age 
have also been reported for other steroid receptor systems (8, 9). 
There was no apparent difference in the percentage of intestinal 
receptor that was able to bind to MÂ-cellulose for either young or 
aged rats, irrespective of the time period involved. This observation 
would seem to discount the presence of an endogenous inhibitor of DNA 
binding in the cytosol of aged animals, as has been reported in other 
steroid receptor systems (10, 38-40). 
Immunoblot analysis either failed to detect, or only faintly re­
vealed the 52K receptor protein band of aged intestinal receptor prep­
arations (lane B, Figure 3). Efforts were made to limit potential 
proteolytic degradation (data not shown) which included the use of 
various proteolytic inhibitors, EDTA, and elutlon of bound receptor 
from DNÂ-cellulose by sodium molybdate. None of the manipulations 
appreciably altered the inability to detect the 52K receptor protein 
band of aged intestinal receptor. 
An alternative hypothesis for the failure to detect this band was 
also viable. Namely, that the epitope the monoclonal antibody recog­
nizes in the aged intestinal receptor had been altered or deleted in 
the protein. Because the antibody has been shown to bind to a region 
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near the DNA-bindlng domain of the chick intestinal receptor (41, 42), 
an altered epitope in this area of the protein in the aged animals may 
influence transcriptional activity. This hypothesis was tested and 
eventually dismissed by using gel filtration HPLC. Both young and 
aged intestinal cytosol preparations produced the same characteristic 
shifts in molecular weight at the equivalent concentrations of anti­
body. This implied that changes in the aged receptor were occurring 
either on the DNA-cellulose column or in the post-column elutions. 
This latter possibility was investigated by preparing young and 
aged receptor and then mixing pooled young and aged intestinal recep­
tor preparations eluted from DNA-cellulose columns (lane D, Figure 3). 
An equivalent amount of pooled young receptor solution was withheld to 
act as the control (lane C, Figure 3). Immunoblots clearly showed 
that the mixed receptor solution resulted in the diminlshment of the 
52K receptor band that was still present in the young receptor control 
blot. Several additional low molecular weight bands also appeared in 
the mixed receptor experiment undoubtedly arising from more extensive 
proteolysis of the protein. It would appear that these observations 
are consistent with the presence of some protease activity, perhaps at 
a much higher activity in aged rats than In young animals, that co-
purifies with the aged intestinal receptor isolated from DNA-cellulose 
chromatography. The inability to appreciably precipitate intestinal 
receptor from aged rats with 40% ammonium sulfate would further sup­
port this hypothesis. Further saturation to 70%, while precipitating 
the majority of the radlolabelled material, did not increase the 
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Immunological detection of receptor from aged rats on Western blots. 
It remains to be seen if this protease activity Is specific for the 
vitamin D receptor or is simply an age-related endogenous enzyme that 
co-purifies on DNÂ-cellulose chromatography. 
The concentration of kidney receptor is significantly lower than 
the intestine, but there is no apparent difference between young and 
aged kidney receptor concentrations (Table 3). There is, however, a 
marked decrease in the ability of aged receptor to bind to DNA-cellu-
lose, despite the equivalence of receptor concentrations with the 
young rats. This may imply the presence of an endogenous inhibitor In 
the kidney cytosols of aged rats (10, 38-40). 
Immunoblots from kidney preparations surprisingly revealed two 
receptor protein bands at approximately 52K and 50K. This would ap­
pear to explain the broad nature of the receptor peaks eluted from 
either young or aged preparations by DNA-cellulose chromatography. 
Evidently, the two forms have slightly different affinities for DNÂ. 
It Is possible the lower molecular weight form (30K) is the result of 
proteolysis of the larger (52K) receptor species (43), although multi­
ple transcripts may also be possible (44). A similar type of observa­
tion has been made from receptor prepared from chicken intestine (43, 
44), but this is the first report of such a phenomenon in a mammalian 
system. 
The results of the preliminary study presented here indicated 
marked age-related differences in both the intestinal and kidney re­
ceptor for vitamin D. There is a lower concentration of intestinal 
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receptor with age, which, together with a decreased plasma l,25-(0H)2Dg 
concentration, may work In tandem to limit the ability to absorb cal­
cium. The percentage of binding to DNA, however, does not seem sig­
nificantly different In the Intestine. The work presented from the 
Immunoblots and the gel filtration HPLC suggests that a proteolytic 
enzyme with Increased activity Is present In aged Intestinal prepara­
tions. Both the receptor concentration and the percent DNA binding 
are lower In the kidney preparations, but receptor prepared from aged 
kidney evidently is blocked from binding to DNA to a greater extent 
than that from young rats. The presence of an inhibitor to DNA bind­
ing would effectively reduce the ability of the aged kidney to respond 
to hormone. In addition, two forms of kidney receptor are visible in 
the immunoblots of either young or aged rats. The two forms are not 
well resolved on DNA-cellulose chromatography, but do display a slight 
difference In their affinity for DNA. Collectively, these data may be 
an aid to explaining the physiological changes that occur to calcium 
homeostasis as a function of age. 
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SUMMARY AND DISCUSSION 
The identification of vitamin D metabolites has, in the past, 
relied primarily upon ultraviolet absorbance, mass spectroscopy, and 
chemical derivatives. The paper in Section I details efforts to uti­
lize NMR spectroscopy to aid in the identification of vitamin Dg 
metabolites. The uniqueness of the vitamin Dg side chain, which in­
cludes a double bond and an additional methyl group, creates distinct 
resonance signals for the side chain moieties. It is certainly rea­
sonable, however, to expect that the methodology developed here could 
prove useful in the identification of vitamin Dg metabolites as well. 
High-resolution spectra were obtained on as little as 5 yg of metabo­
lite (ca. 90 yM). This represents a significant improvement over pre­
vious reports, yet the method is still less sensitive than mass spec­
troscopy. It does offer, however, the advantage that precious metabo­
lite may be recovered intact. The steady improvement in magnet design 
will undoubtedly result in the capability to obtain spectra of nano­
gram quantities of vitamin D metabolites. 
Equally important was the reassignment of the C-21 and C-28 methyl 
group signals in the NMR spectrum of vitamin Dg. An examination of a 
variety of vitamin D^  and selected vitamin D^  metabolites clearly in­
dicated that previous reports had erroneously misassigned the two sig­
nals. It is evident from this work that the C-21 methyl group gives 
rise to the doublet at 51.03, while the C-28 methyl group appears as 
the doublet at 60.90. 
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The ability to obtain high-resolution NMR spectra of microgram 
quantities of vitamin D metabolites was of critical Importance In as­
certaining the structure of 24,26-(011)21)2* a new physiological metabo­
lite of vitamin D2. Conventional means of Identifying the metabolite 
had been unsuccessful, but the NMR spectrum readily placed the po­
sition of the hydroxyl groups In the side chain. The mass spectrum 
was unique for the even-numbered loss from the molecular Ion, and was 
attributed to an Intramolecular rearrangement of the 1,3-dlol. As 
discussed In Section II, this metabolite was unresponsive when tested 
in traditional bioassays, displayed a reduced affinity for the plasma 
vitamin D-bindlng protein, and most likely represents a means of inac­
tivating 24-OHD2. The pathway from vitamin D2 —* 24,26-
(OHOgDg is significant because it represents an important deviation 
from the documented metabolic pathways of vitamin Dg. The exact loca­
tion and specificity of the 26-hydroxylase remains to be determined. 
Because of the limited amount of material isolated it was also not 
possible to account for the stereochemistry of the molecule either at 
C-24 or C-25. There was no indication that multiple Isomers were iso­
lated in this study. 
Perhaps overlooked in this work was the inability to Identify the 
presence of 25,26-(OH)2D2. On the other hand, 25,26-(OH)20^  has been 
determined to be a physiological derivative in the metabolism of vita­
min Dg (82, 83). The failure to detect the formation of 25,26-(OH)2D2 
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In the present study may be an additional divergence of vitamin Dg and 
vitamin metabolic pathways. 
The preliminary study examining the effects that age has on the 
l,25-(0H)2Dg steroid receptor protein in rats should provide a good 
basis for further research. There are several aspects of this work 
that will require additional experiments, the first of which would be 
to reexamine the time-dependent decline in aged intestinal receptor 
concentration. The feeling of this author is that the decline may, in 
fact, be related to the general health of the animals upon arrival. 
Many of the aged animals that initially arrived in the laboratory 
appeared ill, and numbers obtained from these rats may have skewed the 
overall distribution. Given adequate time those sick animals eventu­
ally recovered (or died as in two cases), and receptor numbers re­
flected their "true" status; i.e., significantly lower relative to the 
young rats. It is interesting to note, however, that none of the young 
animals developed any signs of sickness. 
Diet may be a further consideration that needs to be addressed; 
however, a comparison of the two diets revealed only subtle differ­
ences. Both diets more than adequately meet the requirements needed 
for a young, growing rat, or for the maintenance of an aged rat. Nev­
ertheless, it is an area that should be considered in future work. 
The observation that Immunoblots failed to appreciably demon­
strate intestinal receptor from aged rats deserves closer inspection. 
The results from this study would seem to indicate the presence of a 
protease in the aged cytosols that co-purlfies with the receptor on 
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D&A-cellulose. It would be Interesting to determine If this activity 
was specifc for the vitamin D receptor, or was somehow related to the 
altered metabolism of vitamin D with age. The activity may also be 
present In the cytosols of young rats, but at a lower degree of activ­
ity that then permits the detection of the 52K band on the Immunoblots. 
Inclusion of the kidney receptor for vitamin D In this work 
yielded two surprising observations. The first of these pertained to 
the inability of the aged receptor to bind to DNÂ-cellulose as avidly 
as that displayed by similar preparations from young rats. This would 
imply that an inhibitor to DNA binding is present in the cytosol of 
aged rats. Alternatively, one cannot dismiss the possibllty that an 
enhancer to binding exists in the young cytosols (38, 84). A series 
of mixing experiments examining whether or not this putative inhibitor 
could negatively influence DNA binding in other vitamin D receptor 
preparations would be useful. 
Secondly, the detection of two protein bands at 52K and 50K spe­
cific for the kidney receptor was unexpected. The broad nature of the 
DNA-binding peaks from the kidney preparations Indicates the two forms 
possess slightly different affinities for binding. Whether or not the 
two forms arise as the result of proteolysis during the cytosol prepa­
ration or actually represent the existence of multiple transcripts of 
the receptor in kidney needs to be answered. 
In summary, the work Included in this dissertation has exploited 
the recent advances in NMR spectroscopy to aid in the identifica­
tion of vitamin Dg metabolites. It has also resulted in the 
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Identification of a new, physiological vitamin metabolite, 24,26-
(OHÏgDg. The Isolation and characterization of this compound firmly 
establishes an alternative pathway In the metabolism of vitamin not 
available In the vitamin Dg system. The age-related study on the 
vitamin D receptor Indicated that aged animals evidently possess lower 
concentrations of Intestinal receptor. This work also suggested that 
a protease activity, the nature of which Is unknown, co-purlfles par­
ticularly with Intestinal receptor from aged rats when chromatographed 
on DNA-cellulose. Multiple forms of the kidney receptor appeared In 
Immunoblots of both young and aged rats. In addition, cytosollc re­
ceptor extracts from the kidneys of aged rats displayed a much lower 
percent binding to DNA-cellulose than similar preparations from young 
rats. These results may serve to aid in further understanding the 
differences in calcium homeostasis between young and aged animals. 
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